Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 765.00K | 8.72M | 4.19M | 7.55M | 4.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 765.00K | 8.72M | 4.19M | 7.55M | 4.09M |
| Cost of Revenue | 12.04M | 11.75M | 12.20M | 11.86M | 12.91M |
| Gross Profit | -11.28M | -3.02M | -8.01M | -4.30M | -8.82M |
| SG&A Expenses | 11.13M | 12.45M | 12.33M | 12.41M | 12.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.17M | 24.19M | 24.53M | 24.27M | 25.80M |
| Operating Income | -22.40M | -15.47M | -20.34M | -16.72M | -21.71M |
| Income Before Tax | -20.92M | -14.80M | -21.38M | -15.31M | -20.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.92M | -14.80M | -21.38M | -15.31M | -20.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.92M | -14.80M | -21.38M | -15.31M | -20.43M |
| EBIT | -22.40M | -15.47M | -20.34M | -16.72M | -21.71M |
| EBITDA | -21.27M | -14.33M | -19.17M | -15.54M | -20.45M |
| EPS Basic | -3.12 | -2.21 | -3.20 | -2.29 | -3.07 |
| Normalized Basic EPS | -1.90 | -1.27 | -1.70 | -1.32 | -1.77 |
| EPS Diluted | -3.12 | -2.21 | -3.20 | -2.29 | -3.07 |
| Normalized Diluted EPS | -1.90 | -1.27 | -1.70 | -1.32 | -1.77 |
| Average Basic Shares Outstanding | 6.70M | 6.70M | 6.68M | 6.67M | 6.65M |
| Average Diluted Shares Outstanding | 6.70M | 6.70M | 6.68M | 6.67M | 6.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |